triglitazone

triglitazone

Rezulin® Diabetology An agent used as a monotherapy for Pts with type 2 DM with diet and exercise, or combined with sulfonylurea Adverse effects Liver injury or failure
References in periodicals archive ?
They point out that such was the case with triglitazone, a drug for diabetes that was taken off the market after several cases of acute liver failure were reported, despite the issuance of multiple warning letters from the US Food and Drug Administration recommending routine ALT monitoring.